ArticleJournal of cellular biochemistry2020

Pharmacological inhibition of the MEK5/ERK5 and PI3K/Akt signaling pathways synergistically reduces viability in triple-negative breast cancer.

Thomas D Wright et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.